Entos Pharmaceuticals Inc.
$250,000.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- April 1, 2025 – March 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q1-1029894
Published purpose
In partnership with a large Multinational Pharmaceutical Partner, the Firm will evaluate the safety and effectiveness of its Fusogenix formulations optimized for delivery of genetic medicines to the trabecular meshwork of the eye to treat ophthalmological diseases. The project will validate previously optimized trabecular meshwork formulations combined with the pharma partners mRNA cargo and Entos cargoes including DNA in small and large animal models.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions